Bencherif Merouane

CIK 00012958311 companyWINSTON-SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001295831

Recent Transactions

50 trades

Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2013-01-17+40,000→ 40,000 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2012-05-18−15,938→ 7,970 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2012-05-18$2.93/sh+15,938→ 15,938 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2012-05-04+90,000→ 90,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-29+40,000→ 40,000 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-01-19$5.55/sh+7,951→ 7,951 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-01-19$1.75/sh+22,252→ 30,203 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-01-19$27.09/sh−30,203→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-01-19−7,951→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-01-19−22,252→ 0 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-01-18$27.17/sh−22,800→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-01-18$5.55/sh+22,800→ 22,800 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-01-18−22,800→ 7,951 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-10−14,275→ 14,280 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-10−10,624→ 23,908 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-10$8.51/sh+14,275→ 21,469 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-10$24.05/sh−32,093→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-10$2.93/sh+10,624→ 32,093 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-10$5.55/sh+7,194→ 7,194 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-10−7,194→ 30,751 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-19+40,000→ 40,000 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-15−16,049→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-15−6,456→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-15−10,750→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-15−15,975→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-15−19,926→ 37,945 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-01-15$5.10/sh+37,207→ 37,207 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-01-15$1.75/sh+15,975→ 53,182 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-01-15$5.55/sh+19,926→ 73,108 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-01-15$20.51/sh−73,108→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-15−3,952→ 0 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-01-04$20.81/sh−7,735→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-16$8.51/sh+15,532→ 23,267 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-12-16−15,532→ 28,555 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-16$21.93/sh−15,532→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-12-15−8,056→ 44,087 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-15$22.19/sh−8,056→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-15$8.51/sh+8,056→ 15,791 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-14$22.45/sh−6,533→ 12,702 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-14$8.51/sh+4,967→ 20,670 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-14$22.44/sh−1,435→ 19,235 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-14$22.45/sh−4,967→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-12-14−7,968→ 34,532 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-14$2.93/sh+7,968→ 15,703 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-12-14−4,967→ 52,143 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-07-28−5,562→ 22,252 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-07-28$1.75/sh+25,000→ 32,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-07-28−6,451→ 16,049 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-07-28$1.75/sh+4,200→ 36,935 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-07-28$5.10/sh+6,451→ 48,948 total

Companies

GYRE THERAPEUTICS, INC.
VP, Preclinical Research
$GYRE

Recent Filings

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101

View on SEC.gov